HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.

AbstractBACKGROUND:
We investigated the influence of killer cell immunoglobulin-like receptor (KIR) genes, based on the genotypes of inhibitory or activating KIR, in stem cell recipients with acute myelogenous leukemia and their human leukocyte antigen-matched sibling donors on acute graft-versus host disease (GVHD) after hematopoietic stem cell transplantation.
METHODS:
We studied 53 consecutive donor-recipient pairs to determine the impact of KIR genotypes and their bidirectional KIR interactions.
RESULTS:
All activating KIR genes in donors were important factors for determining outcome in a manner distinctive for each gene studied. Specifically, the 2DS2 gene and the 2DS4*003 allele were closely correlated with acute GVHD. The 2DS1 gene was associated with a better long-term survival, even if present only in the donor and not the recipient. The 2DS3-2DS5 dual genes were more often involved in a variety of transplant-related complications.
CONCLUSIONS:
In conclusion, these factors may help predict transplant outcomes and aid in our understanding of immunogenetic specificity.
AuthorsHee-Je Kim, Young Choi, Woo-Sung Min, Tai-Gyu Kim, Byung-Sik Cho, Sung-Yong Kim, Ki-Sung Eom, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, Jong-Wook Lee, Chun-Choo Kim
JournalTransplantation (Transplantation) Vol. 84 Issue 9 Pg. 1082-91 (Nov 15 2007) ISSN: 0041-1337 [Print] United States
PMID17998861 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, KIR
Topics
  • Cytomegalovirus Infections (epidemiology)
  • Gene Frequency
  • Genotype
  • Graft Survival
  • Graft vs Host Disease (epidemiology, immunology)
  • Hematopoietic Stem Cell Transplantation
  • Histocompatibility Testing
  • Humans
  • Killer Cells, Natural (immunology)
  • Leukemia, Myeloid, Acute (therapy)
  • Lymphocyte Activation
  • Postoperative Complications (epidemiology)
  • Receptors, KIR (genetics, immunology)
  • Siblings
  • Transplantation Conditioning
  • Transplantation, Homologous
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: